<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT2012121511758N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2013-01-05</date_registration>
      <primary_sponsor>Vice-Chancellor for Reseach of Tehran University of Medical Science</primary_sponsor>
      <public_title>Comparison  effectiveness of educaion and telenursing on self-management in adult with Epilepsy</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the effectiveness of educaional intrervention based Adult Learning Theory- with and without telephone follow up by nurse(telenursing) on self-management in adult with Epilepsy</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2012-07-29</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>120</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/11910</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: Localization-related (focal)(partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset. Condition 2: Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures. Condition 3: Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures. Condition 4: Generalized idiopathic epilepsy and epileptic syndromes. Condition 5: Other generalized epilepsy and epileptic syndromes. Condition 6: Special epileptic syndromes. Condition 7: Grand mal seizures, unspecified (with or without petit mal). Condition 8: Petit mal, unspecified, without grand mal seizures. Condition 9: Other epilepsy. Condition 10: Epilepsy, unspecified.</hc_freetext>
      <i_freetext>Intervention 1: Education based on Adult Learning Theory  - The education program was developed to be delivered in a group discussion for approximately 10–12 individuals, meeting for a 1-hour once per week for 4 consecutive .The curriculum included a mixture of psychosocial and medical information topics framed in the self-management activities.The overriding theme of self-management was built into all sessions, session materials, and session discussions. For example, meeting 1 focused on information management, Topics that were discussed in detail focused on definition of epilepsy, type of seizure, diagnosis and treatment. Other discussed topic was medication management (such as maintaining blood levels of medications, side effects, drug toxicity identification), seizure triggers and life style management, including sleep, exercise, stress, smoking and other risky behaviors, safety management, psychosocial factors such as depression, stigma, occupation, marriage, social interaction and etc. We also solicited input from the group participants on each topic throughout the discussion and encouraged sharing of personal histories, experiences, perspectives, and approaches to self-management. Group leaders helped to identify the self-management strategies used by participants in real-life scenarios. Intervention 2: Education based on Adult Learning Theory plus Telephone Follow up by Nurse - The education program was developed to be de 1-hourblock of time once per week for 4 consecutive weeks. The curriculum included a mixture of psychosocial and medical information topics framed in the self-management activities.The overriding theme of self-management was built into all sessions, session materials, and session discussions. For example, meeting 1 focused on information management. Topics that were discussed in detail focused on definition of epilepsy, type of seizure, diagnosis and treatment. Other discussed topic was medication management (such as maintaining blood levels of medications, side effects, drug toxicity identification), seizure triggers and life style management, including sleep, exercise, stress, smoking and other risky behaviors, safety management, psychosocial factors such as depression, stigma, occupation, marriage, social interaction and etc. We also solicited input from the group participants on each topic throughout the discussion and encouraged sharing of personal histories, experiences, perspectives, and approaches to self-management. Group leaders helped to identify the self-managementstrategies used by participants in real-life scenarios. &#13;
This session was followed by six telephone- based on sessions content over the next 2 months (first month weekly and second month every 2 week)  aimed at enhancing self-management practices in thefollowing areas: medication, information, seizure, safety, and lifestyle. For each of the phone contact, the nurses first discussed medication management with the participant.The nurse began by asking a general question about medication-taking practices. Participants who were taking medications as prescribed and had no difficulties were encouraged to continue with their regimen. Those who reported problems with medications(e.g., nonadherence or side effects) were provided supportin weighing the costs and benefits of adherence, eliciting barriersto adherence and supporting efforts to solve the barriers to adherence. Following the discussion of medications, the nurse asked the participant to select one or two other self-management components that were important to him or her. The subsequent discussion was directed toward identifying barriers and facilitators of desired behaviors(e.g., reducing stress). Participants were encouraged to develop their own solutions and devise an action plan. Intervention 3: The participants enrolled in the control group received no intervention.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan></results_IPD_plan>
      <results_IPD_description></results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Elham Bagheri Baghabrishami</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Nursing and Midwifery, Tehran University of Medical Sciences, Nosrat St., Tohid Sq., Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip></zip>
        <telephone>+98 21 6692 7171</telephone>
        <email>elsa.1384@yahoo.co</email>
        <affiliation>Tehran university of medical sience</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Zahra Rahnavard</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Nursing and Midwifery, Tehran University of Medical Sciences, Nosrat St., Tohid Sq., Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip></zip>
        <telephone>+98 21 6692 7171</telephone>
        <email>zahra.rahnavard@gmail.com</email>
        <affiliation>Tehran University of Medical Science</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Individuals were eligible if they had been diagnosed of epilepsy by a neurologist,  diagnosed with epilepsy for at least 6 months; were receiving antiepileptic drugs (AEDs); were 18 years old and elder ; were able to understand and speak Persian ; had a telephone (or access to one).Residents in Isfahan and its surrounding.&#13;
&#13;
         Exclusion criteria:&#13;
	Unwilling to participate in Clinical Trial&#13;
	Hospitalized for any reason during the training sessions&#13;
	Non participate in any of education session (in education and  education plus telephone follow up groups)&#13;
-	No answer to 2 or more phone contacts(in education plus telephone follow up group)</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>139 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G40.0</hc_code>
      <hc_code>G40.1</hc_code>
      <hc_code>G40.2</hc_code>
      <hc_code>G40.3</hc_code>
      <hc_code>G40.4</hc_code>
      <hc_code>G40.5</hc_code>
      <hc_code>G40.6</hc_code>
      <hc_code>G40.7</hc_code>
      <hc_code>G40.8</hc_code>
      <hc_code>G40.9</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Incl.: Benign childhood epilepsy with centrotemporal EEG spikes- Childhood epilepsy with occipital EEG paroxysms</hc_keyword>
      <hc_keyword>Incl.: Attacks without alteration of consciousness- Simple partial seizures developing into secondarily generalized seizures</hc_keyword>
      <hc_keyword>Incl.: Attacks with alteration of consciousness, often with automatisms- Complex partial seizures developing into secondarily generalized seizures</hc_keyword>
      <hc_keyword>Incl.:Benign: myoclonic epilepsy in infancy- neonatal convulsions (familial)- Childhood absence epilepsy [pyknolepsy]- Epilepsy with grand mal seizures on awakening- Juvenile: absence epilepsy- myoclonic epilepsy [impulsive petit mal]- Nonspecific epilept</hc_keyword>
      <hc_keyword>Incl.:Epilepsy with: myoclonic absences- myoclonic-astatic seizures- Infantile spasms- Lennox-Gastaut syndrome-Salaam attacks- Symptomatic early myoclonic encephalopathy- West syndrome</hc_keyword>
      <hc_keyword>Incl.: Epilepsia partialis continua [Kozhevnikof]- Epileptic seizures related to: alcohol, drugs, hormonal changes, sleep deprivation, stress</hc_keyword>
      <hc_keyword></hc_keyword>
      <hc_keyword></hc_keyword>
      <hc_keyword>Incl.: Epilepsies and epileptic syndromes undetermined as to whether they are focal or generalized</hc_keyword>
      <hc_keyword>Incl.: Epileptic: convulsions NOS- fits NOS- seizures NOS</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
      <i_code>Other</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Education based on Adult Learning Theory  - The education program was developed to be delivered in a group discussion for approximately 10–12 individuals, meeting for a 1-hour once per week for 4 consecutive .The curriculum included a mixture of psychosocial and medical information topics framed in the self-management activities.The overriding theme of self-management was built into all sessions, session materials, and session discussions. For example, meeting 1 focused on information management, Topics that were discussed in detail focused on definition of epilepsy, type of seizure, diagnosis and treatment. Other discussed topic was medication management (such as maintaining blood levels of medications, side effects, drug toxicity identification), seizure triggers and life style management, including sleep, exercise, stress, smoking and other risky behaviors, safety management, psychosocial factors such as depression, stigma, occupation, marriage, social interaction and etc. We also solicited input from the group participants on each topic throughout the discussion and encouraged sharing of personal histories, experiences, perspectives, and approaches to self-management. Group leaders helped to identify the self-management strategies used by participants in real-life scenarios.</i_keyword>
      <i_keyword>Education based on Adult Learning Theory plus Telephone Follow up by Nurse - The education program was developed to be de 1-hourblock of time once per week for 4 consecutive weeks. The curriculum included a mixture of psychosocial and medical information topics framed in the self-management activities.The overriding theme of self-management was built into all sessions, session materials, and session discussions. For example, meeting 1 focused on information management. Topics that were discussed in detail focused on definition of epilepsy, type of seizure, diagnosis and treatment. Other discussed topic was medication management (such as maintaining blood levels of medications, side effects, drug toxicity identification), seizure triggers and life style management, including sleep, exercise, stress, smoking and other risky behaviors, safety management, psychosocial factors such as depression, stigma, occupation, marriage, social interaction and etc. We also solicited input from the group participants on each topic throughout the discussion and encouraged sharing of personal histories, experiences, perspectives, and approaches to self-management. Group leaders helped to identify the self-managementstrategies used by participants in real-life scenarios. &#13;
This session was followed by six telephone- based on sessions content over the next 2 months (first month weekly and second month every 2 week)  aimed at enhancing self-management practices in thefollowing areas: medication, information, seizure, safety, and lifestyle. For each of the phone contact, the nurses first discussed medication management with the participant.The nurse began by asking a general question about medication-taking practices. Participants who were taking medications as prescribed and had no difficulties were encouraged to continue with their regimen. Those who reported problems with medications(e.g., nonadherence or side effects) were provided supportin weighing the costs and benefits of adherence, eliciting barriersto adherence and supporting efforts to solve the barriers to adherence. Following the discussion of medications, the nurse asked the participant to select one or two other self-management components that were important to him or her. The subsequent discussion was directed toward identifying barriers and facilitators of desired behaviors(e.g., reducing stress). Participants were encouraged to develop their own solutions and devise an action plan.</i_keyword>
      <i_keyword>The participants enrolled in the control group received no intervention.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Epilepsy self-management. Timepoint: At baseline - 4months after. Method of measurement: Epilepsy Self-Management Scale(ESMS).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Age. Timepoint: At baseline. Method of measurement: Demographic information.</sec_outcome>
      <sec_outcome>Gender. Timepoint: At baseline. Method of measurement: Demographic information.</sec_outcome>
      <sec_outcome>Education level. Timepoint: At baseline. Method of measurement: Demographic information.</sec_outcome>
      <sec_outcome>Marital status. Timepoint: At baseline. Method of measurement: Demographic information.</sec_outcome>
      <sec_outcome>Occupation. Timepoint: At baseline. Method of measurement: Demographic information.</sec_outcome>
      <sec_outcome>Economic status. Timepoint: At baseline. Method of measurement: Demographic information.</sec_outcome>
      <sec_outcome>Insurance. Timepoint: At baseline. Method of measurement: Demographic information.</sec_outcome>
      <sec_outcome>Duration of disease. Timepoint: At baseline. Method of measurement: Demographic information.</sec_outcome>
      <sec_outcome>Type of seizure. Timepoint: At baseline. Method of measurement: Demographic information.</sec_outcome>
      <sec_outcome>Number of Antiepileptic Drugs. Timepoint: At baseline. Method of measurement: Demographic information.</sec_outcome>
      <sec_outcome>Frequency of seizure. Timepoint: At baseline. Method of measurement: Demographic information.</sec_outcome>
      <sec_outcome>Other disease. Timepoint: At baseline. Method of measurement: Demographic information.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Vice-Chancellor for Reseach of Tehran University of Medical Science</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2012-07-29</approval_date>
        <contact_name>Tehran University of Medical Science</contact_name>
        <contact_address>Tehran University of Medical Science, Tehran, Iran Tehran  Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
